Related references
Note: Only part of the references are listed.Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
Sergio E. Alvarez et al.
NATURE (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer
A. Rodriguez-Gonzalez et al.
ONCOGENE (2008)
Plasma membrane localization signals in the light chain of botulinum neurotoxin
E Fernández-Salas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
E Fernández-Salas et al.
MOVEMENT DISORDERS (2004)
Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A - Basis for distinct durations of inhibition of exocytosis in central neurons
PG Foran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFα and suppression of NF-κB activities
VN Ivanov et al.
ONCOGENE (2001)
Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle
M Adler et al.
TOXICON (2001)
Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins
PB Zhou et al.
MOLECULAR CELL (2000)
Share Paper
